AngioDynamics Revenue 2012-2025 | ANGO
AngioDynamics revenue from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
AngioDynamics Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $292 |
| 2024 | $304 |
| 2023 | $339 |
| 2022 | $316 |
| 2021 | $291 |
| 2020 | $264 |
| 2019 | $271 |
| 2018 | $262 |
| 2017 | $270 |
| 2016 | $354 |
| 2015 | $357 |
| 2014 | $354 |
| 2013 | $342 |
| 2012 | $222 |
| 2011 | $216 |
|
AngioDynamics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-08-31 | $76 |
| 2025-05-31 | $80 |
| 2025-02-28 | $72 |
| 2024-11-30 | $73 |
| 2024-08-31 | $67 |
| 2024-05-31 | $71 |
| 2024-02-29 | $75 |
| 2023-11-30 | $79 |
| 2023-08-31 | $79 |
| 2023-05-31 | $91 |
| 2023-02-28 | $81 |
| 2022-11-30 | $85 |
| 2022-08-31 | $82 |
| 2022-05-31 | $87 |
| 2022-02-28 | $74 |
| 2021-11-30 | $78 |
| 2021-08-31 | $77 |
| 2021-05-31 | $77 |
| 2021-02-28 | $71 |
| 2020-11-30 | $73 |
| 2020-08-31 | $70 |
| 2020-05-31 | $58 |
| 2020-02-29 | $70 |
| 2019-11-30 | $70 |
| 2019-08-31 | $66 |
| 2019-05-31 | $71 |
| 2019-02-28 | $66 |
| 2018-11-30 | $70 |
| 2018-08-31 | $64 |
| 2018-05-31 | $6 |
| 2018-02-28 | $84 |
| 2017-11-30 | $87 |
| 2017-08-31 | $85 |
| 2017-05-31 | $7 |
| 2017-02-28 | $86 |
| 2016-11-30 | $89 |
| 2016-08-31 | $88 |
| 2016-05-31 | $93 |
| 2016-02-29 | $87 |
| 2015-11-30 | $89 |
| 2015-08-31 | $84 |
| 2015-05-31 | $90 |
| 2015-02-28 | $87 |
| 2014-11-30 | $92 |
| 2014-08-31 | $87 |
| 2014-05-31 | $94 |
| 2014-02-28 | $88 |
| 2013-11-30 | $89 |
| 2013-08-31 | $84 |
| 2013-05-31 | $90 |
| 2013-02-28 | $82 |
| 2012-11-30 | $87 |
| 2012-08-31 | $83 |
| 2012-05-31 | $58 |
| 2012-02-29 | $52 |
| 2011-11-30 | $58 |
| 2011-08-31 | $54 |
| 2011-05-31 | $56 |
| 2011-02-28 | $55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.554B | $0.293B |
| AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.497B | 25.84 |
| Intuitive Surgical (ISRG) | United States | $196.216B | 76.77 |
| IDEXX Laboratories (IDXX) | United States | $56.495B | 56.11 |
| Edwards Lifesciences (EW) | United States | $48.884B | 32.78 |
| Alcon (ALC) | Switzerland | $38.848B | 26.25 |
| IQVIA Holdings (IQV) | United States | $38.484B | 21.46 |
| Mettler-Toledo (MTD) | United States | $29.041B | 33.98 |
| DexCom (DXCM) | United States | $26.888B | 37.06 |
| STERIS (STE) | Ireland | $24.781B | 25.58 |
| Waters (WAT) | United States | $23.350B | 30.88 |
| Hologic (HOLX) | United States | $16.680B | 17.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.086B | 0.00 |
| Penumbra (PEN) | United States | $12.195B | 85.79 |
| Globus Medical (GMED) | United States | $11.896B | 24.97 |
| Masimo (MASI) | United States | $7.589B | 24.32 |
| Glaukos (GKOS) | United States | $6.274B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.005B | 19.08 |
| Teleflex (TFX) | United States | $5.624B | 8.96 |
| TransMedics (TMDX) | United States | $4.361B | 51.67 |
| LivaNova (LIVN) | United Kingdom | $3.492B | 18.86 |
| Veracyte (VCYT) | United States | $3.337B | 38.04 |
| Alphatec Holdings (ATEC) | United States | $2.958B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.535B | 11.90 |
| Elekta AB (EKTAY) | Sweden | $2.212B | 20.69 |
| Artivion (AORT) | United States | $2.155B | 98.87 |
| PROCEPT BioRobotics (PRCT) | United States | $2.013B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.804B | 15.75 |
| UFP Technologies (UFPT) | United States | $1.657B | 21.88 |
| Tandem Diabetes Care (TNDM) | United States | $1.422B | 0.00 |
| AxoGen (AXGN) | United States | $1.383B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.290B | 0.00 |
| IRadimed (IRMD) | United States | $1.239B | 59.02 |
| Integra LifeSciences Holdings (IART) | United States | $1.094B | 5.93 |
| OPKO Health (OPK) | United States | $1.067B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.932B | 0.00 |
| SiBone (SIBN) | United States | $0.817B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.655B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.631B | 36.66 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.622B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.549B | 10.95 |
| NeuroPace (NPCE) | United States | $0.549B | 0.00 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.460B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.438B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.434B | 11.98 |
| Alpha Tau Medical (DRTS) | Israel | $0.421B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 61.12 |
| Semler Scientific (SMLR) | United States | $0.294B | 2.19 |
| Spectral Diagnostics (EDTXF) | Canada | $0.275B | 0.00 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| CVRx (CVRX) | United States | $0.221B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.218B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.216B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.185B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.165B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.160B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.157B | 0.00 |
| Solana (HSDT) | United States | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.106B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.088B | 0.00 |
| DarioHealth (DRIO) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.064B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.24 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |